Recombinant Glycoprotein Vaccines for Human Immunodeficiency Virus-Infected Children and Their Effects on Viral Quasispecies
In individuals infected with human immunodeficiency virus type 1 (HIV-1), specific immunity is associated with a more diverse viral repertoire and slower disease progression. Attempts to enhance antiviral immunity with therapeutic vaccination have shown that recombinant glycoprotein (RGP) vaccines a...
Na minha lista:
| Publicado no: | Clin Diagn Lab Immunol |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
2002
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC119877/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11777833/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/CDLI.9.1.79-82.2002 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
